Chemomab Therapeutics CMMB
NASDAQ CMMB
$1.61 -0.03 (-1.83%)
At close: Sep 29, 2026 · 4:00 PM EDT

Chemomab Therapeutics (CMMB) Restructuring Costs (2020)

Updated

Chemomab Therapeutics (CMMB) reported Restructuring Costs of $749,000 for FY2020, down 77.6% from $3.35 million in FY2019.

Analysis

Chemomab Therapeutics (CMMB) Restructuring Costs (2020) Analysis & Trends

  • According to Business Quant data, Restructuring Costs came in at $3.35 million in FY2019.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Chemomab Therapeutics 11.80 Mn 11.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 79,000.00
Mar 31, 2020 670,000.00
API Access

Chemomab Therapeutics Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=CMMB&period=max&api_key=YOUR_API_KEY